Paxlovid - direct healthcare professional communication (DHPC)

nirmatrelvir / ritonavir

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Paxlovid (nirmatrelvir; ritonavir): reminder of life-threatening and fatal drug-drug interactions with certain immunosuppressants, including tacrolimus

Key facts

• Medicine name:
  Paxlovid
• Active substance:
  • nirmatrelvir
  • ritonavir
• Therapeutic area (MeSH):
  COVID-19 virus infection
• Regulatory outcome:
  Maintenance
• DHPC type:
  Adverse event
• Human ATC codes:
  J05AE30
• Dissemination date:
  21/03/2024